Negative regulation of cytokine signaling - PubMed (original) (raw)
Affiliations
- PMID: 11527983
Review
Negative regulation of cytokine signaling
C J Greenhalgh et al. J Leukoc Biol. 2001 Sep.
Abstract
Cytokines use complex signaling cascades to elicit their biological effects, many of which involve phosphorylation as a mechanism of activation. Rapid and efficient attenuation of cytokine signals is crucial to maintaining regulation of these processes and to preventing toxic side effects. Phosphatases have been shown to be involved in these regulatory processes, but more recent research has seen the discovery of two new families of negative regulators, the suppressor of cytokine signaling (SOCS) and protein inhibitors of signal transducer and activator of transcription (STAT) (PIAS) protein families. SOCS proteins are induced by and inhibit many cytokine-signaling systems in a classic negative-feedback loop, and the generation of transgenic and knockout models has greatly increased our understanding of their physiological functions. PIAS proteins interact with the transcriptional mediators of cytokine action, the STATs, to suppress their DNA-binding activity. These three classes of molecules form what is now emerging as an integrated system for deactivating cytokine signaling at a number of levels, from the receptor to the transcription factor.
Similar articles
- Negative regulators of cytokine signaling.
Kile BT, Nicola NA, Alexander WS. Kile BT, et al. Int J Hematol. 2001 Apr;73(3):292-8. doi: 10.1007/BF02981953. Int J Hematol. 2001. PMID: 11345194 Review. - SOCS proteins: negative regulators of cytokine signaling.
Krebs DL, Hilton DJ. Krebs DL, et al. Stem Cells. 2001;19(5):378-87. doi: 10.1634/stemcells.19-5-378. Stem Cells. 2001. PMID: 11553846 Review. - A new role for SOCS in insulin action. Suppressor of cytokine signaling.
Krebs DL, Hilton DJ. Krebs DL, et al. Sci STKE. 2003 Feb 11;2003(169):PE6. doi: 10.1126/stke.2003.169.pe6. Sci STKE. 2003. PMID: 12582200 Review. - Suppressors of cytokine signalling (SOCS): putative modulators of cytokine bioactivity in health and disease.
Diamond P, Doran P, Brady HR, McGinty A. Diamond P, et al. J Nephrol. 2000 Jan-Feb;13(1):9-14. J Nephrol. 2000. PMID: 10720209 Review. - Controlling cytokine signaling by constitutive inhibitors.
Rakesh K, Agrawal DK. Rakesh K, et al. Biochem Pharmacol. 2005 Sep 1;70(5):649-57. doi: 10.1016/j.bcp.2005.04.042. Biochem Pharmacol. 2005. PMID: 15936728 Review.
Cited by
- A Novel Anti-Inflammatory d-Peptide Inhibits Disease Phenotype Progression in an ALS Mouse Model.
Post J, Kogel V, Schaffrath A, Lohmann P, Shah NJ, Langen KJ, Willbold D, Willuweit A, Kutzsche J. Post J, et al. Molecules. 2021 Mar 13;26(6):1590. doi: 10.3390/molecules26061590. Molecules. 2021. PMID: 33805709 Free PMC article. - SCF(HOS) ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-alpha receptor.
Kumar KG, Tang W, Ravindranath AK, Clark WA, Croze E, Fuchs SY. Kumar KG, et al. EMBO J. 2003 Oct 15;22(20):5480-90. doi: 10.1093/emboj/cdg524. EMBO J. 2003. PMID: 14532120 Free PMC article. - The role of the JAK/STAT signal pathway in rheumatoid arthritis.
Malemud CJ. Malemud CJ. Ther Adv Musculoskelet Dis. 2018 Jun;10(5-6):117-127. doi: 10.1177/1759720X18776224. Epub 2018 May 19. Ther Adv Musculoskelet Dis. 2018. PMID: 29942363 Free PMC article. Review. - Mast cell homeostasis and the JAK-STAT pathway.
Morales JK, Falanga YT, Depcrynski A, Fernando J, Ryan JJ. Morales JK, et al. Genes Immun. 2010 Dec;11(8):599-608. doi: 10.1038/gene.2010.35. Epub 2010 Jun 10. Genes Immun. 2010. PMID: 20535135 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources